glp-1 and family history of thyroid cancer GLP-1RA cancer: New study suggests detection bias, not causation Glucagon-Like Peptide-1 Receptor Agonists and

Strawberry Flavor with Clean-Label Ingredients: Enjoy a naturally sweet, refreshing strawberry flavor with no added sugar, alcohol, or artificial sweeteners

BEHIND THE HYPE-- GLP-1 MEDS: We spent months digging into the benefits and costs involving GLP-1 medications

Many therapy areas had high growth in days of therapy in 2023 led by GLP-1 agonists driving obesity and diabetes. As the bar chart clearly tells us from the 3rd line on the bottom of the graph, obesity leads the top 30 therapy areas by growth from 2022

Regulatory pressure, lower prices, and new retail agreements are shifting the balance in the US GLP-1 market.

Here's what clinicians should know.

Recently, BCGs Center for Customer Insight (CCI) surveyed more than 1,500 GLP-1 users in nine markets.